• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Bright Horizons Family Solutions and Remitly Global Set to Join S&P SmallCap 600

    5/7/26 6:01:00 PM ET
    $APLS
    $BFAM
    $BIIB
    $RELY
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Other Consumer Services
    Consumer Discretionary
    Get the next $APLS alert in real time by email

    NEW YORK, May 7, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600 effective prior to the opening of trading on Thursday, May 14:

    • Bright Horizons Family Solutions Inc. (NYSE:BFAM) will replace Tri Pointe Homes Inc. (NYSE:TPH). Sumitomo Forestry Group (TSE: 1911) is acquiring Tri Pointe Homes in a deal expected to close soon, pending final closing conditions.
    • Remitly Global Inc. (NASD: RELY) will replace Apellis Pharmaceuticals Inc. (NASD: APLS). S&P 500 constituent Biogen Inc. (NASD: BIIB) is acquiring Apellis Pharmaceuticals in a deal expected to close soon, pending final closing conditions.

    Following is a summary of the changes that will take place prior to the open of trading on the effective date:

    Effective Date

    Index Name      

    Action

    Company Name

    Ticker

    GICS Sector

    May 14, 2026

    S&P SmallCap 600

    Addition

    Bright Horizons Family Solutions

    BFAM

    Consumer Discretionary

    May 14, 2026

    S&P SmallCap 600

    Deletion

    Tri Pointe Homes

    TPH

    Consumer Discretionary

    May 14, 2026

    S&P SmallCap 600

    Addition

    Remitly Global

    RELY

    Financials

    May 14, 2026

    S&P SmallCap 600

    Deletion

    Apellis Pharmaceuticals

    APLS

    Health Care

    ABOUT S&P DOW JONES INDICES

    S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.

    S&P Dow Jones Indices is a division of S&P Global (NYSE:SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spglobal.com/spdji/en/.

    FOR MORE INFORMATION:

    S&P Dow Jones Indices

    index_services@spglobal.com

    Media Inquiries

    spdji.comms@spglobal.com

    Cision View original content:https://www.prnewswire.com/news-releases/bright-horizons-family-solutions-and-remitly-global-set-to-join-sp-smallcap-600-302766326.html

    SOURCE S&P Dow Jones Indices

    Get the next $APLS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $APLS
    $BFAM
    $BIIB
    $RELY

    CompanyDatePrice TargetRatingAnalyst
    Biogen Inc.
    $BIIB
    5/15/2026Outperform
    Evercore ISI
    Remitly Global Inc.
    $RELY
    5/7/2026$30.00 → $33.00Buy
    Monness Crespi & Hardt
    Biogen Inc.
    $BIIB
    4/22/2026$225.00Neutral → Buy
    UBS
    Biogen Inc.
    $BIIB
    4/20/2026$250.00Equal Weight → Overweight
    Wells Fargo
    Biogen Inc.
    $BIIB
    4/14/2026$214.00Neutral → Overweight
    Piper Sandler
    Apellis Pharmaceuticals Inc.
    $APLS
    3/13/2026$31.00Buy
    Roth Capital
    Biogen Inc.
    $BIIB
    2/20/2026$185.00Equal Weight
    Barclays
    S&P Global Inc.
    $SPGI
    2/17/2026$575.00Buy
    BofA Securities
    More analyst ratings

    $APLS
    $BFAM
    $BIIB
    $RELY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Moritz Robert Edward Jr. bought $500,001 worth of shares (1,152 units at $434.03) (SEC Form 4)

    4 - S&P Global Inc. (0000064040) (Issuer)

    5/4/26 4:19:22 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    CEO, S&P Dow Jones Indices Clay Catherine R bought $1,078,475 worth of shares (2,500 units at $431.39) (SEC Form 4)

    4 - S&P Global Inc. (0000064040) (Issuer)

    5/4/26 4:18:28 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    CEO & President Cheung Martina bought $998,297 worth of shares (2,322 units at $429.93), increasing direct ownership by 9% to 27,518 units (SEC Form 4)

    4 - S&P Global Inc. (0000064040) (Issuer)

    5/1/26 4:07:01 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    $APLS
    $BFAM
    $BIIB
    $RELY
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZURZUVAE issued to BIOGEN INC

    Submission status for BIOGEN INC's drug ZURZUVAE (SUPPL-3) with active ingredient ZURANOLONE has changed to 'Approval' on 04/20/2026. Application Category: NDA, Application Number: 217369, Application Classification: Labeling

    4/23/26 6:14:48 PM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for VUMERITY issued to BIOGEN INC

    Submission status for BIOGEN INC's drug VUMERITY (ORIG-1) with active ingredient DIROXIMEL FUMARATE has changed to 'Approval' on 09/12/2024. Application Category: NDA, Application Number: 761347, Application Classification: Type 3 - New Dosage Form

    9/16/24 6:52:10 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for VUMERITY issued to BIOGEN INC

    Submission status for BIOGEN INC's drug VUMERITY (SUPPL-17) with active ingredient DIROXIMEL FUMARATE has changed to 'Approval' on 09/11/2024. Application Category: NDA, Application Number: 211855, Application Classification: Manufacturing (CMC)

    9/16/24 6:24:32 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $APLS
    $BFAM
    $BIIB
    $RELY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Evercore ISI resumed coverage on Biogen

    Evercore ISI resumed coverage of Biogen with a rating of Outperform

    5/15/26 8:16:23 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Monness Crespi & Hardt reiterated coverage on Remitly Global with a new price target

    Monness Crespi & Hardt reiterated coverage of Remitly Global with a rating of Buy and set a new price target of $33.00 from $30.00 previously

    5/7/26 7:58:28 AM ET
    $RELY
    Real Estate

    Biogen upgraded by UBS with a new price target

    UBS upgraded Biogen from Neutral to Buy and set a new price target of $225.00

    4/22/26 7:42:32 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $APLS
    $BFAM
    $BIIB
    $RELY
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Apellis Pharmaceuticals Inc.

    SCHEDULE 13G/A - Apellis Pharmaceuticals, Inc. (0001492422) (Subject)

    6/5/26 4:14:08 PM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Biogen Inc.

    SCHEDULE 13G/A - BIOGEN INC. (0000875045) (Subject)

    6/5/26 10:13:06 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Bright Horizons Family Solutions Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - BRIGHT HORIZONS FAMILY SOLUTIONS INC. (0001437578) (Filer)

    6/3/26 4:25:11 PM ET
    $BFAM
    Other Consumer Services
    Consumer Discretionary

    $APLS
    $BFAM
    $BIIB
    $RELY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Marvell Technology and Flex Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, June 5, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, June 22, 2026, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from S&P MidCap 400 and S&P SmallCap 600 are no longer representative of the mid-cap and small-cap market space, respectively.  Following is a summary of the changes that will take place prior to the open of trading on the effective date:Effective DateIndex Name       ActionCompany NameTickerGICS SectorJune 22, 2026

    6/5/26 7:25:00 PM ET
    $BLKB
    $BRBR
    $CABO
    Computer Software: Prepackaged Software
    Technology
    Packaged Foods
    Consumer Staples

    S&P Global to Present at Mizuho Technology Conference 2026 on June 10, 2026

    Session will be WebcastNEW YORK, June 5, 2026 /PRNewswire/ -- Mark Grant, Senior Vice President of Investor Relations and Treasurer of S&P Global (NYSE: SPGI), will participate in the Mizuho Technology Conference 2026 on June 10, 2026 in New York, New York. Mr. Grant is scheduled to speak from 10:30 a.m. to 11:05 a.m. (Eastern Daylight Time). The "fireside chat" will be webcast and may include forward-looking information. Heather Balsky, Senior Director of Investor Relations will join for investor meetings. Webcast Instructions:  Live and ReplayThe webcast (audio-only) will be available live and in replay through the Company's Investor Relations website http://investor.spglobal.com/Investor-

    6/5/26 4:50:00 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index

    TORONTO, June 5, 2026 /CNW/ - As a result of the quarterly review, S&P Dow Jones Indices will make the following changes in the S&P/TSX Composite Index prior to the open of trading on Monday, June 22, 2026: S&P/TSX COMPOSITE INDEX – June 22, 2026COMPANYGICS SECTORGICS SUB-INDUSTRYADDEDAltius Minerals Corp (TSX:ALS)MaterialsDiversified Metals & MiningADDEDExtendicare Inc. (TSX:EXE)HealthcareHealth Care FacilitiesADDEDHammond Power Solutions Inc. (TSX:HPS)IndustrialsElectrical Components & EquipmentADDEDSpartan Delta Corp. (TSX:SDE)EnergyOil & Gas Exploration & ProductionADDEDSouthern Cross Gold Consolidated Ltd. (TSX:SXGC)MaterialsGoldDELETEDgoeasy Ltd. (TSX:GSY)FinancialConsumer FinanceDELET

    6/5/26 4:15:00 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    $APLS
    $BFAM
    $BIIB
    $RELY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lissy David H was granted 2,096 shares, increasing direct ownership by 9% to 24,911 units (SEC Form 4)

    4 - BRIGHT HORIZONS FAMILY SOLUTIONS INC. (0001437578) (Issuer)

    6/5/26 7:04:18 PM ET
    $BFAM
    Other Consumer Services
    Consumer Discretionary

    Director Alleva Lawrence M was granted 2,096 shares, increasing direct ownership by 19% to 13,336 units (SEC Form 4)

    4 - BRIGHT HORIZONS FAMILY SOLUTIONS INC. (0001437578) (Issuer)

    6/5/26 7:03:50 PM ET
    $BFAM
    Other Consumer Services
    Consumer Discretionary

    Director Atkinson Julie was granted 2,096 shares, increasing direct ownership by 23% to 11,378 units (SEC Form 4)

    4 - BRIGHT HORIZONS FAMILY SOLUTIONS INC. (0001437578) (Issuer)

    6/5/26 7:03:34 PM ET
    $BFAM
    Other Consumer Services
    Consumer Discretionary

    $APLS
    $BFAM
    $BIIB
    $RELY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Apellis Pharmaceuticals Inc.

    SC 13G/A - Apellis Pharmaceuticals, Inc. (0001492422) (Subject)

    11/22/24 4:16:13 PM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Apellis Pharmaceuticals Inc.

    SC 13G - Apellis Pharmaceuticals, Inc. (0001492422) (Subject)

    11/22/24 8:47:59 AM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Bright Horizons Family Solutions Inc.

    SC 13G/A - BRIGHT HORIZONS FAMILY SOLUTIONS INC. (0001437578) (Subject)

    11/14/24 5:56:31 PM ET
    $BFAM
    Other Consumer Services
    Consumer Discretionary

    $APLS
    $BFAM
    $BIIB
    $RELY
    Financials

    Live finance-specific insights

    View All

    EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus

    Steroid use reduction and disease control: In additional results from the Phase 3 PHOENYCS GO study, dapirolizumab pegol (DZP) plus standard of care was associated with sustained disease control at lower glucocorticoid doses through Week 48 compared with placebo plus standard of care, supporting reduced long-term steroid exposureReduced flare rates and immune marker improvements: In other findings presented at EULAR 2026, improvements in immunological markers and reduced flare rates were observed, supporting the potential of dapirolizumab pegol to address the complex burden of SLE BRUSSELS, Belgium and CAMBRIDGE, Mass., June 04, 2026 (GLOBE NEWSWIRE) -- UCB (Euronext Brussels: UCB) and Bi

    6/4/26 1:00:00 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus

    Publication adds to previously reported findings from Phase 3 PHOENYCS GO study, demonstrating statistically significant improvement in disease activity at Week 48 with dapirolizumab pegol plus standard of care versus placebo plus standard of careFindings showed results in favor of dapirolizumab pegol plus standard of care versus placebo plus standard of care across endpoints, including multiple disease activity measures, severe flares, patient-reported outcomes, including fatigue, and glucocorticoid taperingResults support the continued development of dapirolizumab pegol; the ongoing confirmatory Phase 3 PHOENYCS FLY clinical trial is currently recruiting BRUSSELS, Belgium and CAMBRIDGE, M

    6/1/26 1:30:00 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    S&P Global Announces Leadership Change for Market Intelligence, Evolution of Enterprise Data, Technology & Transformation

    Saugata Saha to depart the Company July 30, 2026Enterprise Data, Technology & Transformation Organizations Combine to Unlock Greater Value and InnovationNEW YORK, May 26, 2026 /PRNewswire/ -- S&P Global (NYSE: SPGI) announced today that Saugata Saha, President of S&P Global Market Intelligence and Chief Enterprise Data Officer, has decided to leave the company to pursue another opportunity. Mr. Saha will remain with S&P Global through July 30, 2026, to support transition. "Saugata is a respected leader and a valued member of our Executive Leadership Team. He leaves Market Intell

    5/26/26 8:47:00 AM ET
    $SPGI
    Finance: Consumer Services
    Finance

    $APLS
    $BFAM
    $BIIB
    $RELY
    Leadership Updates

    Live Leadership Updates

    View All

    Marvell Technology and Flex Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, June 5, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, June 22, 2026, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from S&P MidCap 400 and S&P SmallCap 600 are no longer representative of the mid-cap and small-cap market space, respectively.  Following is a summary of the changes that will take place prior to the open of trading on the effective date:Effective DateIndex Name       ActionCompany NameTickerGICS SectorJune 22, 2026

    6/5/26 7:25:00 PM ET
    $BLKB
    $BRBR
    $CABO
    Computer Software: Prepackaged Software
    Technology
    Packaged Foods
    Consumer Staples

    FedEx Freight Holding Set to Join Dow Jones Transportation Average

    NEW YORK, May 27, 2026 /PRNewswire/ -- FedEx Freight Holding Company Inc. (NYSE:FDXF) will replace American Airlines Group Inc. (NASD:AAL) in the Dow Jones Transportation Average (DJTA) effective prior to the open of trading on Monday, June, 1, 2026. Dow Jones Transportation Average constituent FedEx Corp. (NYSE:FDX) is spinning off FedEx Freight Holding Company in a transaction expected to be completed on June 1. Post spin-off, parent FedEx will remain in the DJTA. American Airlines Group has a low weight in the index of less than one-half of one percentage point caused by its low share price. The Dow Jones Transportation Average is a price weighted index, and thus very low-priced stocks ha

    5/27/26 11:13:00 PM ET
    $AAL
    $FDX
    $SPGI
    Air Freight/Delivery Services
    Consumer Discretionary
    Finance: Consumer Services
    Finance

    FedEx Freight Holding Company Set to Join S&P 500; EPAM Systems and Dave to Join S&P SmallCap 600

    NEW YORK, May 27, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P SmallCap 600:  FedEx Freight Holding Company (NYSE:FDXF) will replace EPAM Systems Inc. (NYSE:EPAM) in the S&P 500, and EPAM Systems will replace Shutterstock Inc. (NYSE:SSTK) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, June 2. S&P 500 & 100 constituent FedEx Corp. (NYSE:FDX) is spinning off FedExFreight Holding in a transaction expected to be completed June 1. Post spin-off, the parent FedEx will remain in the S&P 500 and 100. EPAM Systems is more representative of the small-cap market space. Shutterstock is anticipated to be acquired in a deal t

    5/27/26 6:30:00 PM ET
    $AMWD
    $DAVE
    $EPAM
    Forest Products
    Basic Materials
    Finance: Consumer Services
    Finance